BSE Live
Jan 16, 15:12Prev. Close
69.21
Open Price
69.00
Bid Price (Qty.)
68.02 (602)
Offer Price (Qty.)
68.59 (188)
NSE Live
Jan 16, 15:11Prev. Close
69.23
Open Price
69.99
Bid Price (Qty.)
68.19 (9)
Offer Price (Qty.)
68.46 (7)
| Balance Sheet of Brooks Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||||
| SHAREHOLDER'S FUNDS | |||||
| Equity Share Capital | 4.65 | 2.58 | 0.63 | 0.63 | |
| Total Share Capital | 4.65 | 2.58 | 0.63 | 0.63 | |
| Reserves and Surplus | 8.89 | 5.77 | 4.71 | 1.12 | |
| Total Reserves and Surplus | 8.89 | 5.77 | 4.71 | 1.12 | |
| Total Shareholders Funds | 13.54 | 8.35 | 5.34 | 1.76 | |
| NON-CURRENT LIABILITIES | |||||
| Long Term Borrowings | 11.82 | 16.06 | 12.35 | 8.04 | |
| Deferred Tax Liabilities [Net] | 0.86 | 0.69 | 0.48 | 0.26 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 12.68 | 16.75 | 12.83 | 8.31 | |
| CURRENT LIABILITIES | |||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 10.05 | 6.51 | 7.18 | 4.73 | |
| Short Term Provisions | 0.99 | 0.41 | 0.55 | 0.18 | |
| Total Current Liabilities | 11.04 | 6.92 | 7.73 | 4.91 | |
| Total Capital And Liabilities | 37.30 | 32.05 | 25.89 | 14.98 | |
| ASSETS | |||||
| NON-CURRENT ASSETS | |||||
| Tangible Assets | 19.38 | 17.05 | 9.30 | 8.44 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.02 | 0.06 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 19.40 | 17.12 | 9.30 | 8.44 | |
| Non-Current Investments | 0.02 | 0.02 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.01 | 0.02 | 0.03 | 0.03 | |
| Total Non-Current Assets | 19.43 | 17.16 | 9.32 | 8.47 | |
| CURRENT ASSETS | |||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 4.73 | 3.47 | 4.70 | 1.93 | |
| Trade Receivables | 8.56 | 7.17 | 4.06 | 2.43 | |
| Cash And Cash Equivalents | 0.86 | 2.20 | 5.23 | 0.15 | |
| Short Term Loans And Advances | 3.73 | 2.06 | 2.59 | 2.00 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 17.87 | 14.90 | 16.57 | 6.51 | |
| Total Assets | 37.30 | 32.05 | 25.89 | 14.98 | |
| OTHER ADDITIONAL INFORMATION | |||||
| CONTINGENT LIABILITIES, COMMITMENTS | |||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | |||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||||
| FOB Value Of Goods | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | |
| BONUS DETAILS | |||||
| Bonus Equity Share Capital | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | |||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.02 | 0.02 | -- | -- | |
| CURRENT INVESTMENTS | |||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- |
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y